Taiwan FDA registration 25e8a6fa5af29318f21b9a5424a37eca
Abbott New Generation Hemolytic 1700 System
TW: 亞培新世代血球溶解劑1700系統
Taiwan·Risk Class 1·ABBOTT LABORATORIES·Registered Oct 22, 2010 – Oct 22, 2015CancelledRegistration details
- Analysis ID
- 25e8a6fa5af29318f21b9a5424a37eca
- Customs Code
- DHA04400939601
Company information
- Manufacturer
- ABBOTT LABORATORIES
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- Limited to the first level identification range of red blood cell dissolving agent (B.8540) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.8540 紅血球溶解劑
- Import Information
- import
Dates and status
- Registration Date
- Oct 22, 2010
- Expiry Date
- Oct 22, 2015
- Cancellation Date
- Aug 09, 2018
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for Abbott New Generation Hemolytic 1700 System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 25e8a6fa5af29318f21b9a5424a37eca and manufactured by ABBOTT LABORATORIES. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices